Janux Therapeutics, Inc.
SEC Filing List
JANX CIK: 0001817713
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 08/14/2026 | |||
| SCHEDULE 13G/A | 08/13/2026 | ||||
| 8-K | Current report filing | Janux Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/06/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Janux Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/06/2026 | |
| 4 | Statement of changes in beneficial owner... | Campbell David Alan | Janux Therapeutics, Inc. | 07/31/2026 | |
| SCHEDULE 13G/A | 07/28/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Campbell David Alan | Janux Therapeutics, Inc. | 07/10/2026 | |
| 8-K | Current report filing | Janux Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/23/2026 | |
| 8-K | Current report filing | Janux Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/12/2026 | |
| 4 | Statement of changes in beneficial owner... | Kung Winston | Janux Therapeutics, Inc. | 06/12/2026 | |
| No record found. | |||||
| Load More | |||||
